rs2274516

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_000287.4(PEX6):​c.2644G>A​(p.Val882Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0259 in 1,614,138 control chromosomes in the GnomAD database, including 641 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.021 ( 43 hom., cov: 32)
Exomes 𝑓: 0.026 ( 598 hom. )

Consequence

PEX6
NM_000287.4 missense

Scores

1
17

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 1.61
Variant links:
Genes affected
PEX6 (HGNC:8859): (peroxisomal biogenesis factor 6) This gene encodes a member of the AAA (ATPases associated with diverse cellular activities) family of ATPases. This member is a predominantly cytoplasmic protein, which plays a direct role in peroxisomal protein import and is required for PTS1 (peroxisomal targeting signal 1, a C-terminal tripeptide of the sequence ser-lys-leu) receptor activity. Mutations in this gene cause peroxisome biogenesis disorders of complementation group 4 and complementation group 6. Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.009148866).
BP6
Variant 6-42965097-C-T is Benign according to our data. Variant chr6-42965097-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 255739.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-42965097-C-T is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.021 (3197/152310) while in subpopulation NFE AF= 0.0274 (1866/68030). AF 95% confidence interval is 0.0264. There are 43 homozygotes in gnomad4. There are 1648 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 43 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
PEX6NM_000287.4 linkuse as main transcriptc.2644G>A p.Val882Ile missense_variant 15/17 ENST00000304611.13 NP_000278.3

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
PEX6ENST00000304611.13 linkuse as main transcriptc.2644G>A p.Val882Ile missense_variant 15/171 NM_000287.4 ENSP00000303511 P1Q13608-1
PEX6ENST00000244546.4 linkuse as main transcriptc.*180G>A 3_prime_UTR_variant 13/151 ENSP00000244546 Q13608-2

Frequencies

GnomAD3 genomes
AF:
0.0210
AC:
3202
AN:
152192
Hom.:
43
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00955
Gnomad AMI
AF:
0.0461
Gnomad AMR
AF:
0.00779
Gnomad ASJ
AF:
0.00922
Gnomad EAS
AF:
0.0233
Gnomad SAS
AF:
0.0254
Gnomad FIN
AF:
0.0444
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.0274
Gnomad OTH
AF:
0.0134
GnomAD3 exomes
AF:
0.0226
AC:
5690
AN:
251470
Hom.:
96
AF XY:
0.0234
AC XY:
3175
AN XY:
135908
show subpopulations
Gnomad AFR exome
AF:
0.00861
Gnomad AMR exome
AF:
0.00700
Gnomad ASJ exome
AF:
0.00595
Gnomad EAS exome
AF:
0.0239
Gnomad SAS exome
AF:
0.0249
Gnomad FIN exome
AF:
0.0403
Gnomad NFE exome
AF:
0.0266
Gnomad OTH exome
AF:
0.0239
GnomAD4 exome
AF:
0.0265
AC:
38684
AN:
1461828
Hom.:
598
Cov.:
34
AF XY:
0.0264
AC XY:
19178
AN XY:
727216
show subpopulations
Gnomad4 AFR exome
AF:
0.00756
Gnomad4 AMR exome
AF:
0.00736
Gnomad4 ASJ exome
AF:
0.00627
Gnomad4 EAS exome
AF:
0.0163
Gnomad4 SAS exome
AF:
0.0251
Gnomad4 FIN exome
AF:
0.0397
Gnomad4 NFE exome
AF:
0.0284
Gnomad4 OTH exome
AF:
0.0235
GnomAD4 genome
AF:
0.0210
AC:
3197
AN:
152310
Hom.:
43
Cov.:
32
AF XY:
0.0221
AC XY:
1648
AN XY:
74462
show subpopulations
Gnomad4 AFR
AF:
0.00950
Gnomad4 AMR
AF:
0.00778
Gnomad4 ASJ
AF:
0.00922
Gnomad4 EAS
AF:
0.0231
Gnomad4 SAS
AF:
0.0250
Gnomad4 FIN
AF:
0.0444
Gnomad4 NFE
AF:
0.0274
Gnomad4 OTH
AF:
0.0128
Alfa
AF:
0.0260
Hom.:
95
Bravo
AF:
0.0179
TwinsUK
AF:
0.0267
AC:
99
ALSPAC
AF:
0.0257
AC:
99
ESP6500AA
AF:
0.00862
AC:
38
ESP6500EA
AF:
0.0277
AC:
238
ExAC
AF:
0.0220
AC:
2665
Asia WGS
AF:
0.0230
AC:
79
AN:
3478
EpiCase
AF:
0.0256
EpiControl
AF:
0.0238

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicDec 15, 2015- -
Likely benign, criteria provided, single submitterclinical testingGeneDxJun 22, 2021- -
Benign, criteria provided, single submitterclinical testingAthena DiagnosticsJul 31, 2018- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Peroxisome biogenesis disorder 4A (Zellweger) Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Zellweger spectrum disorders Benign:1
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -
Peroxisome biogenesis disorder Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.095
BayesDel_addAF
Benign
-0.46
T
BayesDel_noAF
Benign
-0.41
CADD
Benign
9.0
DANN
Benign
0.83
DEOGEN2
Benign
0.073
T
Eigen
Benign
-0.68
Eigen_PC
Benign
-0.52
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.81
T
MetaRNN
Benign
0.0091
T
MetaSVM
Benign
-0.51
T
MutationAssessor
Benign
-0.77
N
MutationTaster
Benign
1.0
D;D
PrimateAI
Benign
0.35
T
PROVEAN
Benign
0.11
N
REVEL
Benign
0.29
Sift
Benign
1.0
T
Sift4G
Benign
0.63
T
Polyphen
0.46
P
Vest4
0.060
MPC
0.12
ClinPred
0.0090
T
GERP RS
2.6
Varity_R
0.021
gMVP
0.33

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2274516; hg19: chr6-42932835; API